Back to Search Start Over

Tolerogenic Dendritic Cells Attenuate Experimental Autoimmune Antimyeloperoxidase Glomerulonephritis.

Authors :
Odobasic D
Oudin V
Ito K
Gan PY
Kitching AR
Holdsworth SR
Source :
Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2019 Nov; Vol. 30 (11), pp. 2140-2157. Date of Electronic Publication: 2019 Aug 23.
Publication Year :
2019

Abstract

Background Because of their capacity to induce antigen-specific immunosuppression, tolerogenic dendritic cells are a promising tool for treatment of autoimmune conditions, such as GN caused by autoimmunity against myeloperoxidase (MPO).<br />Methods: We sought to generate tolerogenic dendritic cells to suppress anti-MPO GN by culturing bone marrow cells with an NF κ B inhibitor (BAY 11-7082) and exposing them to a pulse of MPO. After administering these MPO/BAY dendritic cells or saline to mice with established anti-MPO or anti-methylated BSA (mBSA) immunity, we assessed immune responses and GN. We also examined mechanisms of action of MPO/BAY dendritic cells.<br />Results: MPO/BAY dendritic cells decreased anti-MPO immunity and GN without inhibiting immune responses against mBSA; they also induced IL-10-producing regulatory T cells in MPO-immunized mice without affecting IL-10 <superscript>+</superscript> CD4 <superscript>+</superscript> Foxp3 <superscript>-</superscript> type 1 regulatory T cells or regulatory B cells. MPO/BAY dendritic cells did not inhibit anti-MPO immunity when CD4 <superscript>+</superscript> Foxp3 <superscript>+</superscript> cells were depleted in vivo , showing that regulatory T cells are required for their effects. Coculture experiments with dendritic cells and CD4 <superscript>+</superscript> Foxp3 <superscript>-</superscript> or CD4 <superscript>+</superscript> Foxp3 <superscript>+</superscript> cells showed that MPO/BAY dendritic cells generate Foxp3 <superscript>+</superscript> regulatory T cells from CD4 <superscript>+</superscript> Foxp3 <superscript>-</superscript> cells through several pathways, and induce IL-10 <superscript>+</superscript> regulatory T cells via inducible costimulator (ICOS), which was confirmed in vivo . Transfer of MPO/BAY dendritic cell-induced regulatory T cells in vivo , with or without anti-IL-10 receptor antibody, demonstrated that they suppress anti-MPO immunity and GN via IL-10.<br />Conclusions: MPO/BAY dendritic cells attenuate established anti-MPO autoimmunity and GN in an antigen-specific manner through ICOS-dependent induction of IL-10-expressing regulatory T cells. This suggests that autoantigen-loaded tolerogenic dendritic cells may represent a novel antigen-specific therapeutic option for anti-MPO GN.<br /> (Copyright © 2019 by the American Society of Nephrology.)

Details

Language :
English
ISSN :
1533-3450
Volume :
30
Issue :
11
Database :
MEDLINE
Journal :
Journal of the American Society of Nephrology : JASN
Publication Type :
Academic Journal
Accession number :
31444274
Full Text :
https://doi.org/10.1681/ASN.2019030236